Guidance for using rapid diagnostic tests for Ebola in the United States
Supporting Files
Public Domain
-
December 16, 2019
-
Series: Health Alert Network
File Language:
English
Details
-
Corporate Authors:
-
Description:Distributed via the CDC Health Alert Network
December 16, 2019, 1400 EST (2:00 PM EST)
CDCHAN-00423
In October 2019, the U.S. Food and Drug Administration (FDA) allowed marketing of the OraQuick® Ebola Rapid Antigen Test, a rapid diagnostic test (RDT) for detecting Ebola virus in both symptomatic patients and recently deceased people. This is the first Ebola RDT that FDA has allowed for marketing in the United States. The RDT should be used only in cases where more sensitive molecular testing is not available. All OraQuick® Ebola Rapid Antigen Test results are presumptive; all test results (positive and negative) must be verified through real-time reverse transcriptase polymerase chain reaction (rRT-PCR) testing at a Laboratory Response Network (LRN) laboratory located in 49 states and at the Centers for Disease Control and Prevention (CDC). Interpretation of RDT results should be done with caution and in consultation with relevant public health authorities to ensure appropriate testing and interpretation of results. RDT results should not be used to rule out Ebola infection or to determine the use or type of infection prevention and control precautions when managing a patient with Ebola compatible symptoms and epidemiologic risk factors. Healthcare providers with a patient with possible Ebola virus infection should first contact their local or state public health authorities before any testing is performed. CDC is available to provide consultation, technical assistance, and confirmatory testing as necessary.
-
Subjects:
-
Source:HAN ; 423
-
Series:
-
Document Type:
-
Place as Subject:
-
Issue:423
-
Collection(s):
-
Main Document Checksum:urn:sha-512:1342f1aa9b13118aee0ebcbc9ddf20694871236c468047a095dbc59a1a8ad80830864b78147c8a83e2aa9ad1caf756e0f66f4937f96d7e581232f4b50e91d93b
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Health Alert Network (HAN)